logo
Friday's analyst upgrades and downgrades for May 23

Friday's analyst upgrades and downgrades for May 23

Globe and Mail23-05-2025
Inside the Market's roundup of some of today's key analyst actions
Desjardins Securities analyst Doug Young saw the second-quarter results from Toronto-Dominion Bank (TD-T) as 'encouraging' after cash earnings per share and adjusted pre-tax, pre-provision (PTPP) earnings exceeded his estimates by 16 per cent and 8 per cent, respectively.
'Much of the beat came from wealth management, insurance and capital markets (tougher to model), as well as better-than expected credit performance, which remains difficult to forecast in this environment— hence, 'slightly [positive]',' he said.
Shares of TD rose 3.2 per cent on Thursday following the premarket quarterly release and disclosure of a plan to reduce its work force by 2 per cent as part of a cost-cutting plan while the lender fixes gaps in its anti-money-laundering processes. Cash EPS Cash EPS came in at $1.97, topping both Mr. Young's $1.70 projection and the consensus forecast on the Street of $1.75 as wealth management (and insurance), capital markets and U.S. retail all topped estimates.
In a note released Friday, Mr. Young summarized the release by saying, 'Positives. (1) Solid beat. (2) Credit trends were encouraging. PCLs [provisions for credit losses] were below our forecast and new GIL formations declined sequentially. It provided disclosure on tariff-impacted commercial exposures (approximately 9 per cent of gross loans) and the watch list declined in all business segments. While it did not change its total PCL rate guidance for FY25 (45–55 basis points), there are risks to it given the macro backdrop. (3) US retail adjusted PTPP earnings were 2 per cent above our estimate. The balance sheet restructuring is on plan (expected to hit the upper end of its US$300–500-million NII benefit in FY25, with more in FY26). There was nothing new on the AML file. (4) Wealth management (and insurance) adjusted PTPP earnings were well above our estimate.
'Concerns. Canadian P&C adjusted PTPP earnings were 3 per cent below both our estimate and consensus. While a few items weighed on results this quarter, management is optimistic.'
After raising his cash EPS forecast through 2026, Mr. Young increased his target for TD shares to $97 from $95. The average target on the Street is $93.86, according to LSEG data.
'We maintain our Hold rating, but we are warming up to the name,' he concluded.
Elsewhere, others making target adjustments include:
* National Bank's Gabriel Dechaine to $98 from $80 with a 'sector perform' rating.
'We are increasing our 2025 and 2026 estimates to reflect higher interest income, primarily. We are also increasing our 2026E target multiple to 11.5 times from 10 times to reflect greater confidence in our earnings forecasts. As a result of these changes, our target goes to $98 from $80,' said Mr. Dechaine.
* RBC's Darko Mihelic to $93 from $87 with a 'sector perform' rating.
'Q2/25 results were strong with lower than expected impaired provisions for credit loss (PCLs), partially offset by higher than anticipated expenses and a credible performing PCL build,' said Mr. Mihelic. 'TD announced a restructuring program and an Investor Day this fall. We expect TD to be slightly above its expense guidance for 2025, but view the restructuring program positively. We still view our TD model as 'under construction' and most likely to change over the next couple of quarters but view our estimates as conservative. We increase our EPS estimates and raise our price target.'
* Barclays' Brian Morton to $83 from $81 with an 'underweight' rating.
* Scotia's Meny Grauman to $95 from $90 with a 'sector perform' rating.
* Canaccord Genuity's Matthew Lee to $101 from $96 with a 'buy' rating.
=====
Seeing 'reduced visibility' and a 'softer outlook' following weaker-than-expected fourth-quarter 2025 financial results, Echelon Capital Markets analyst Amr Ezzat expects shares of Computer Modelling Group Ltd. (CMG-T) to 'remain range-bound over the coming quarters,' leading him to lower his recommendation to 'neutral' from 'buy' previously.
'We approached Q4/F25 cautiously – a stance which turned out to be warranted,' he said. 'CMG delivered a softer-than-expected finish to the year, with revenue ($33.7-million) and EBITDA ($10.5-million) both below consensus ($36.0-million/$11.8-million), and our own estimates ($34.8-million/$11.2-million), which sat at the bottom of the range for sales and near the bottom for EBITDA.
'More notable than the miss, however, was the drop in disclosure. Segment-level details – elements that had become standard in CMG's MD&A since it began making acquisitions – were absent. While the President's letter reaffirmed the outperformance of the acquired businesses relative to legacy solutions, the lack of granularity makes it more difficult to track the pace and effectiveness of that transition.'
Following Thursday's premarket quarterly release, which caused its shares to plummet 17.7 per cent, Mr. Ezzat thinks the operational weakness of the Calgary-based company, which makes software to evaluate underground oil and gas reservoirs, as 'multi-faceted – and admittedly more pronounced than we expected.'
'The U.S. CCS market has cooled, with many tax-incentive-driven feasibility studies (under the IRA) not renewing,' he added. 'Smaller operators are under pressure, and customers are increasingly rationalizing software spend across vendors. Meanwhile, professional services revenue is expected to decline by $6–7-million in F2026, simulation growth visibility has deteriorated faster than anticipated, and while Seismic is a bright spot, it still represents a smaller portion of the mix.
'The stock reaction [Thursday] likely reflects not just the miss, but also investor uncertainty stemming from reduced disclosure, and the market beginning to digest a more rapidly softening simulation outlook. With FQ1 and FQ2 expected to be seasonally weaker and recurring revenue needing to grow 7–8 per cent just to offset the services decline, we believe the stock is likely to remain range-bound in the near term.'
Mr. Ezzat reduced his target for Computer Modelling Group shares to $9 from $14. The average target is $11.
Elsewhere, other target adjustments include:
* National Bank's John Shao to $10 from $13 with an 'outperform' rating.
'CMG reported FQ4 results below our forecasts due to continued macro headwinds that weighed down renewal activity of its marginal customers,' said Mr. Shao. 'As much as the company benefited from strong energy transition-related demand last year, the opposite appears to be happening this quarter, as what used to be a favourable policy environment now turned against it. With the stock pulling back to a recent low and expectations now reset based on a set of clear guidelines, we believe the stock has largely priced in those macro challenges. Looking ahead, the recovery will be driven by a combination of efforts to preserve the core customer base while pursuing M&A for incremental growth. On the latter point, we now believe CMG is at a comfortable spot to deploy more capital as the company expanded its scope to include more targets across the oil and gas value chain. While we've reduced our target based on our estimate revisions that capture the near-term challenges, we reiterate our Outperform rating as we believe M&A as a growth driver remains intact and will accelerate in the coming year.'
* Canaccord Genuity's Doug Taylor to $8 from $12 with a 'hold' rating.
=====
Following first-quarter earnings season, TD Cowen's Aaron MacNeil said the Canadian Midstream sector continues to offer income-oriented investors 'low financial volatility and a growing dividend with an attractive yield.'
In a report released Friday, the analyst updated his 'scorecard' for stocks in the sector, which he said is used to evaluate companies based on 'relative portfolio quality, growth platform, capital structure, track record and the potential impact of prevailing regulatory exposure.'
'TC continues to rank 1st in our scorecard, with Enbridge moving to 2nd (from 3rd),' said Mr. MacNeil. 'Pembina now ranks 3rd (from 2nd), but remains our Top Pick given its combination of asset quality, growth outlook and relative value. Scorecard rankings have a direct read-through to target multiples.
'If You're Explaining, You're Losing: A quote attributable to Ronald Reagan, but extremely applicable in the context of prevailing investor sentiment. Specifically, companies that have provided investors with a clearly articulated long-term growth outlook atop a base of highly contracted cash flows, no single-asset issues or exposure to increasingly challenged marketing operations have outperformed peers since our last scorecard update and over a period of time that featured meaningful macro uncertainty. To this end, our updated scorecard ranking increasingly reflects these preferences.'
Mr. MacNeil made two changes to the six stocks he covers in the sector. They are:
* Enbridge Inc. (ENB-T, 'buy') to $69 from $67
Analyst: " Enbridge moves to 2nd (3rd previously) given similar contract (98 per cent)/growth thematics to TC. We believe Enbridge's discount to TC is a function of its crude oil exposure. We view Enbridge's oil exposure as a non-issue, but do not expect the valuation gap to narrow.'
* Pembina Pipeline Corp. (PPL-T, 'buy') to $64 from $66.
Analyst: 'Pembina moves to 3rd (2nd previously) given changes to our ranking of growth outlook and recent headwinds affecting its track record ranking. Pembina remains our Top Pick, noting that it is the only Canadian midstream company trading below its 10-year mean.'
He maintained a 'buy' rating and $76 target for top pick TC Energy Corp. (TRP-T).
'TC continues to top our scorecard ranking, due to its contracted cash flows (97 per cent) as well as its growth outlook. Investors are attributing a premium value on the name and it is a beneficiary of current funds flows,' he explained.
=====
While emphasizing High Liner Foods Inc. (HLF-T) has 'not been immune to recent industry headwinds,' RBC Dominion Securities analyst Ryland Conrad see 'a long runway for seafood consumption growth in North America and management continues to execute against its profitable growth strategy underpinned by expanded distribution and innovation.'
However, he initiated coverage of the Lunenburg, N.S.-based company with a 'sector perform' rating on Friday, preferring to 'remain on the sidelines given the challenging demand environment and look for greater visibility on potential catalysts' after a share price performance over the last 12 months (up 37 per cent).
'We believe High Liner is well positioned to navigate headwinds including an uncertain macro backdrop, value-seeking consumer behaviour and a challenging outlook for out-of-home dining, leaning on: (i) a wide range of products, brands and price points across retail (approximately 33 per cent of revenues); (ii) a stable non-commercial foodservice business (40 per cent of revenues); and (iii) strong market positioning with a manufacturing presence in both the U.S. and Canada,' said Mr. Conrad.
'Despite a long runway for seafood consumption growth in North America and strong execution against the company's profitable growth strategy, we see more headwinds (macro uncertainty, raw material inflation, moderating population growth, elevated promotional activity) than tailwinds for volume growth in the near-term with risk skewing to the downside. As such, we are taking a cautious approach to our forecast through 2026 (we forecast a 2024-2026 adjusted EBITDA CAGR [compound annual growth rate] of 1 per cent).'
Noting aquaculture 'underpins a supportive long-term supply outlook' and seeing the company " actively pursuing M&A with a focus on the North American frozen seafood market," the analyst set a target of $20 per share, pointing to a 'more balanced risk-reward profile following re-rating.' The current average is $20.92.
'At 6.0 times FTM [forward 12-month] EV/ EBITDA (in-line with the five-year historical average), we believe the current valuation is justified, reflecting a balance between the company's defensive characteristics, solid execution, healthy balance sheet and steady FCF generation (2025E FCF yield of 10 per cent), against an uncertain macro backdrop and modest growth outlook,' said Mr. Conrad.
=====
In other analyst actions:
* J.P. Morgan's Tami Zakaria downgraded GFL Environmental Inc. (GFL-N, GFL-T) to 'neutral' from 'overweight' with a US$54 target. The average on the Street is US$56.07.
* In response to the approval of its 3-to-1 consolidation of its common shares in connection with its application to list on the NYSE, National Bank's Mohamed Sidibé increased his Allied Gold Corp. (AAUC-T) target to $27 from $9 with an 'outperform' rating. The average is now $25.29.
* Desjardins Securities' Brent Stadler cut his Green Impact Partners Inc. (GIP-X) target by $1 to $8 with a 'buy' rating. The average is $6.
'We have updated our model following the sale of the water, waste and recycling facilities, which we believe should ease the going-concern issue noted in GIP's 4Q financials,' he said. 'Our focus remains on FEP [Future Energy Park]. GIP announced that it has finalized a non-binding lead equity term sheet with a Japanese company as it marches toward financial close, which could put cash on the balance sheet and drive a recurring management fee.'
* Morgan Stanley's Ioannis Masvoulas raised his Lundin Mining Corp. (LUN-T) target to $12.50 from $12 with an 'equalweight' recommendation. The average is $15.22.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New Maritime subscription box is going to the dogs
New Maritime subscription box is going to the dogs

CTV News

time9 minutes ago

  • CTV News

New Maritime subscription box is going to the dogs

Meet the creators behind a new local subscription box for dogs in this week's Pet Talk. The Maritime Mutt box is a new quarterly subscription box made just for dogs filled with local products. Co-founders Jenna McCarthy and Ryan Casey came up with the idea after working with dogs in Jenna's dog walking business. 'Jenna has been working with dogs for a long time with a dog walking business. So, we have been seeing many different products and so many great local suppliers. So, we came up with the idea this summer and thought we would make a go of it,' said Casey in an interview with CTV News Atlantic's Crystal Garret on Tuesday. 'We launched the idea on July 1 to start getting it out there. We have seen great responses from suppliers who want to be in the box to get their products into pets' paws.' McCarthy said many dog owners make their pets a part of their families, so they decided to make their dog Winnie the mascot for the business. 'Anyone who has a dog I find we really make them part of our family. We thought we might as well make her the mascot,' she said. Each box will consist of products locally made in Atlantic Canada like treats, accessories and care products. 'We are looking for products that are high quality. I think a lot of the products made here are great,' said Casey. 'We have accessories, we have care items, treats, nail enhancers, we're looking at all kinds of different things.' 'We're hoping to do a seasonal theme,' said McCarthy, 'So I'm hoping for each box to make it about each season because I think our dogs need change as the seasons change.' The first box will be released in September with one dollar from each box going to the SPCA.

PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?

Globe and Mail

time9 minutes ago

  • Globe and Mail

PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?

The Procter & Gamble Company PG has relied on price increases in recent years to offset inflationary pressures on input costs, but sustaining this strategy indefinitely presents challenges. While fiscal 2025 saw balanced contributions from volume and pricing, management has acknowledged that consumer behavior is shifting as inflation, tariffs and macro uncertainty weigh on purchasing patterns. In some categories, especially in North America and Europe, category growth has slowed, and consumers are seeking value through smaller packs, promotions or lower-priced tiers. This creates a ceiling on the effectiveness of repeated price hikes, as further increases risk driving trade-down or reducing category growth. PG's ability to maintain pricing power depends heavily on its brand superiority and innovation pipeline. Management emphasized that categories where performance has slipped below consumer expectations have seen share pressure, but regaining superiority quickly reaccelerates growth. Examples such as innovation in Pampers, SK-II and Swiffer demonstrate that when product performance and value are clearly communicated, the company can command premium pricing even in a cost-sensitive environment. PG is working on cutting costs, improving its supply chain and focusing on its most profitable products to handle ongoing inflation. The company is aiming for up to $1.5 billion in yearly savings and is removing less important products so it can invest in the best ones. But with $200 million in extra commodity costs and $1 billion in tariffs expected in 2026, PG will need more than just price hikes. It plans to combine smarter pricing with cost savings and innovations to stay ahead. PG's Peers: How CL & CHD Tackle Inflation In an increasingly inflationary and volatile macroeconomic environment, leading consumer goods companies like Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are leveraging strategic price increases and premium innovation to help offset rising input costs. Colgate has been using price increases alongside its premium innovation strategy to help cover rising input costs, including higher raw materials, like fats and oils and the impact of tariffs. In second-quarter 2025, pricing added 80 basis points (bps) to its gross margin, but this was more than offset by a 420-bps hit from raw and packaging material inflation. The company is also relying on 'funding-the-growth' productivity initiatives, which delivered a 250-bps benefit, and is planning further pricing actions in key international markets. For Church & Dwight, price increases have been an important tool to help offset higher costs from raw materials, packaging and tariffs, but the benefit is becoming more limited. In second-quarter 2025, the company saw solid volume gains, yet pricing and mix had only a small positive impact on sales, and inflationary pressures still weighed on margins. Management is balancing selective pricing with productivity improvements, cost controls and innovation to protect profitability, acknowledging that there is a limit to how much consumers will accept higher prices before switching to cheaper alternatives. This means future margin protection will rely more on efficiency gains and premium product growth rather than relying solely on price hikes. PG's Price Performance, Valuation & Estimates Procter & Gamble's shares have lost around 7.5% year to date compared with the industry 's 4.3% dip. From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 22.01X compared with the industry's average of 19.79X. The Zacks Consensus Estimate for PG's fiscal 2025 and 2026 EPS indicates year-over-year growth of 2.3% and 6.3%, respectively. The company's EPS estimates for fiscal 2025 and 2026 have moved downward in the past 30 days. Procter & Gamble currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Colgate-Palmolive Company (CL): Free Stock Analysis Report Church & Dwight Co., Inc. (CHD): Free Stock Analysis Report

Modern Health Welcomes New Chief Technology Officer and General Counsel
Modern Health Welcomes New Chief Technology Officer and General Counsel

National Post

time9 minutes ago

  • National Post

Modern Health Welcomes New Chief Technology Officer and General Counsel

Article content New Data from Modern Health Reinforces Proven Model and Offers Fresh Insight into Evolving Workforce Needs Article content SAN FRANCISCO — Modern Health, a leading global workplace mental health platform, today announced the appointments of Chen Cheng as Chief Technology Officer and Erin Brown as General Counsel, along with other company momentum, as it accelerates its mission to make mental health care more accessible, personalized, and effective worldwide. Article content In her role as Chief Technology Officer, Chen Cheng will oversee the company's technology and further scale the platform to provide high-quality, clinically rigorous care across the globe. She brings more than a decade of experience in the health technology sector to Modern Health, including roles at Oscar Health and ZocDoc. As technology plays an increasingly critical role in expanding access to mental health care and support, evidenced by the growing engagement with virtual therapy, coaching, and digital tools, Chen will leverage her tech experience and leadership to help Modern Health advance its innovations. Article content Erin Brown joins Modern Health as General Counsel, bringing more than 20 years of legal experience across the health and benefits space. Brown has amassed a proven track record of guiding high-growth organizations through complex legal and regulatory environments. Prior to Modern Health, Brown was Senior Vice President and Associate General Counsel at Alight Solutions and, before that, Associate General Counsel at Aon Hewitt. Her expertise and strategic counsel will be key as Modern Health continues to expand its global footprint and innovate responsibly in a rapidly evolving industry. Article content 'Welcoming exceptional leaders like Chen and Erin marks an exciting step forward for Modern Health,' said Matt Levin, CEO of Modern Health. 'They each bring a powerful combination of industry expertise and a passion for making mental health care more accessible, personalized, and effective. Their leadership will accelerate our momentum as we scale our impact, drive innovation, and continue delivering meaningful outcomes for the workplaces we support worldwide.' Article content In addition to these appointments, other recent company momentum includes: Article content Modern Health has been named to the 2025 Inc. 5000 list of the fastest-growing private companies in America. The list highlights companies that have demonstrated significant revenue growth over a three-year period and serves as a benchmark for entrepreneurial success and a platform for recognizing the contributions of these businesses to the US economy. Modern Health launches ROI Study that proves mental health care pays off: According to a third-party analysis of 13,000+ members, the most significant savings (60% of total savings) in health care spend for employers come from reaching more employees earlier with support that fits their needs before symptoms escalate. Modern Health's evidence-based Adaptive Care Model delivers an estimated $2.39 return for every dollar invested, based solely on health care cost savings. These compelling findings underscore how Modern Health's Adaptive Care Model improves outcomes and drives down costs by supporting the whole workforce—not just those with severe mental health concerns. Peer-reviewed data shows Modern Health's global mental health model works anywhere: In one of the largest and most diverse real-world studies of its kind, Modern Health examined engagement and clinical outcomes among more than 33,000 members across seven global regions to understand not only how mental health needs vary across regions but also whether a single care model could truly work at a global scale. The study proves that achieving global scale requires more than a one-size-fits-all approach; it demands an adaptive, evidence-based model designed to deliver meaningful results across diverse regions and populations. Modern Health's latest study paints a stark picture of how Gen Z and Millennial employees are faring: In a study of 1,000 American professionals aged 18 to 44, the findings reveal a generation silently struggling under the weight of burnout, financial anxiety, and workplace systems that haven't kept pace with their needs. Among the most striking statistics: 75% blame financial stress for fueling burnout and hurting productivity, 79% sacrifice mental health to meet work demands, and 96% want access to preventative mental health support. The workplace report highlights a troubling reality: too many young workers are quietly pushing through mounting mental health challenges just to keep up at work, underscoring the urgent need to meet people earlier, with care that's proactive, adaptive, and designed to support the mental health of entire workforce populations. Launch of FlexEAP Challenges Outdated Employee Assistance Programs: Modern Health recently launched FlexEAP ('Flex'), a next-gen Employee Assistance Program (EAP) addressing the critical shortcomings of traditional EAPs by delivering rapid access to care, adaptive support extending far beyond crisis intervention, and a seamless, consistent global experience. The product combines Modern Health's Adaptive Care Model with an elite, global provider network to deliver a seamless, personalized mental health experience. Employees can access care, on average, within 24 hours, with fast, frictionless support across therapy, coaching, crisis intervention, and digital self-guided tools. Flex delivers superior outcomes and an upgraded, consumer-grade experience compared to traditional EAPs, while offering flexible pricing, customizable solutions, and risk-sharing based on utilization—empowering employers to better manage costs. Expanded Languages for Pathways: Modern Health is proud to offer its Pathways Collections, offering tailored one-on-one support around a variety of topics, including Workplace Well-being, Family Care, and Physical Well-Being, as a truly multilingual product. Now, members can connect with a Pathway Provider in six additional languages — Spanish, Dutch, Hindi, Portuguese, Japanese, and French. Article content About Modern Health Article content Modern Health is a global leader in adaptive mental health care, dynamically offering multi-modal mental health support that delivers meaningful outcomes at a sustainable, predictable cost. With therapy, psychiatry, coaching, community groups, self-guided tools, and crisis support, we dynamically create individualized care journeys to address a spectrum of mental health needs and preferences with culturally responsive providers in 200+ countries and territories and 80+ languages. Backed by peer-reviewed research and a proprietary blend of technology and live support, Modern Health delivers measurable outcomes, globally equitable access, and sustainable pricing. Our industry-leading Adaptive Care Model and dedicated, human centered, operationally tuned, customer success partners make us a trusted partner for organizations worldwide. Article content Article content Article content Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store